SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MOREPEN LABORATORIES

BSE: 500288 22 May 2025
Healthcare
₹ 67.87
Morepen Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MOREPEN LABORATORIES - Share Price & Details

Market Cap
₹3,692
High /Low
101.0 / 41.7
Stock P/E
31.3
Book Value
₹21.1
Dividend Yield
0.0
ROCE
15.1
ROE
₹11.8
Face Value
2.0
PEG Ratio
1.1
EVEBITDA
₹19.5
Debt
105
CMP / FCF
-33.8
Debt to equity
₹0.09
NP Ann
118
High price all time
101.0
Piotroski score
₹4.0
Graham Number
32.0
No. Eq. Shares
54.8
Net CF
₹10.4
Net profit
118
Price to book value
3.2
Interest Coverage
₹19.6
Low price all time
2.05
Industry PE
32.1
Reserves
₹1,047
Free Cash Flow
₹-182

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic0.700.190.61NA4.1732.1
Triochem Products Ltd.,4.590.88NA3.600
MOREPEN LABORATORIES LTD.4704.65203.154658.530.353,69231.3
Orchid Pharma Limited2,258.33207.752,173.434.10367633.3
RPG LIFE SCIENCES LTD.1481.51173.51430.90359030.4

Peer Comparison Chart


About MOREPEN LABORATORIES

Morepen Laboratories Ltd., with Security Code 500288, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Morepen Laboratories' (NSE:MOREPENLAB) Promising Earnings May Rest On Soft Foundations

(20 May 2025)
Morepen Laboratories Limited ( NSE:MOREPENLAB ) just reported some strong earnings, and the market reacted accordingly...
Read more →

CDSCO Panel Rejects Morepen Laboratories' Proposal To Waive local Phase III clinical trial of Resmetirom...

(18 May 2025)
New Delhi: Rejecting the proposal for the local Phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the...
Read more →

Morepen Proposes Dividend After 23 Years, Logs Rs 1.18 Bn PAT in FY25

(14 May 2025)
In a landmark announcement that signals a new era of growth and financial strength, Morepen Laboratories board has proposed to declared a...
Read more →

Morepen Labs slides as Q4 PAT decline 29% YoY to Rs 20 crore

(13 May 2025)
Morepen Laboratories slipped 2.83% to Rs 58.67 after the company reported 29.33% decline in consolidated net profit to Rs 20.31 crore in Q4...
Read more →

Dividend ANNOUNCED after 2001; Rs 60 stock price – Pharma company Q4 results

(13 May 2025)
Dividend Stock: The pharma company on Monday, May 12, reported its quarterly earnings. It said the consolidated net profit declined by 31...
Read more →

Morepen Board proposed dividend after 23 years

(13 May 2025)
Morepen Laboratories board has proposed to declare a dividend (Rs. 0.20 per share) after a gap of 23 years, marking a defining moment in the...
Read more →